Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Related Articles by Review for PubMed (Select 19158425)

1.

Ascorbic acid and rates of cognitive decline in Alzheimer's disease.

Bowman GL, Dodge H, Frei B, Calabrese C, Oken BS, Kaye JA, Quinn JF.

J Alzheimers Dis. 2009;16(1):93-8. doi: 10.3233/JAD-2009-0923.

2.

Ascorbic acid and the brain: rationale for the use against cognitive decline.

Harrison FE, Bowman GL, Polidori MC.

Nutrients. 2014 Apr 24;6(4):1752-81. doi: 10.3390/nu6041752. Review.

3.

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Hampel H, B├╝rger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K.

Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Epub 2007 Dec 21. Review.

PMID:
18631949
4.

[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].

Croisile B, Auriacombe S, Etcharry-Bouyx F, Vercelletto M; National Institute on Aging (u.s.); Alzheimer Association.

Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12. Review. French.

PMID:
22579080
5.

Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.

Levey A, Lah J, Goldstein F, Steenland K, Bliwise D.

Clin Ther. 2006 Jul;28(7):991-1001. Review.

PMID:
16990077
6.

Ascorbic acid, cognitive function, and Alzheimer's disease: a current review and future direction.

Bowman GL.

Biofactors. 2012 Mar-Apr;38(2):114-22. doi: 10.1002/biof.1002. Epub 2012 Mar 15. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk